Antegenes
Innovative genetic tests for cancer prevention
Antegenes has raised €2.8M across 2 funding rounds from 3 investors, most recently a round in Aug 2022. Based in Tartu, Estonia; active in Healthtech. Data as of 28 Oct 2026.
Tartu, Estoniaantegenes.com ↗
Total raised
€2.8M
€2,800,000
Funding rounds
2
Investors
3
distinct backers
Active since
2021-11
latest 2022-08
Funding by year
EUR raised per yearAntegenes — funding by year — interactive chart.
Data table
| Antegenes — funding by year | |
|---|---|
| 2021 | €500k |
| 2022 | €2.3M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-08-02 | Other | €2.3M | Enterprise Estonia,European Institute of Innovation and Technology | View deal → |
| 2021-11-10 | Other | €500k | Everything Genetic | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Bolt€1.8BEstonia · Transportation
- CMR Surgical€1.5BUK · Healthtech
- Wise€1.4BEstonia · Fintech
- Roivant Sciences€1.1BSwitzerland · Healthtech
Global coverage: FundingData